Mydri Atropine 1% (Ophthalmic Solution)

5 ml drop: ৳ 30.00

Medicine Details

Product Title

  • Mydri Mydri Atropine Eye Drops 1%
  • Mydri Mydri Atropine Eye Drops 0.01%

Categories

  • Eye Care
  • Myopia Treatment
  • Cycloplegic Agent
  • Mydriatic Agent

Description

  • Indications:
    • Cycloplegic agent for refraction
    • Mydriatic agent for desired dilatation of the iris or uveal tract
    • Treatment to slow the progression of myopia in children aged 4-14 years
  • Composition:
    • Atropine 1% Eye Drops:
      • Atropine Sulphate BP 10 mg
      • Benzalkonium Chloride 0.01% as preservative
    • Atropine 0.01% Eye Drops:
      • Atropine Sulphate USP 0.1 mg
      • Sodium Perborate 0.01% as preservative
  • Pharmacology:
    • Suppression of myopia progression
    • Action via muscarinic receptors in ocular tissues
    • Involvement in ocular growth, development, and accommodation
  • Dosage & Administration:
    • 1% Eye drops:
      • Uveitis - one drop three times daily
      • Refraction - one drop in the eyes twice daily before examination
    • 0.01% Eye drops:
      • Administered as one drop to each eye at night
      • Maximum benefit with a 2-year continued administration period
  • Interaction:
    • Potential interactions with Anticholinergics, Antiglaucoma agents, Potassium Citrate, Potassium Supplements, Carbachol, Physostigmine, Pilocarpine, CNS medication
  • Contraindications:
    • Not to be used in the presence of angle closure glaucoma
    • Estimation of the depth of the angle of the anterior chamber before initiation of therapy in glaucoma-susceptible patients
  • Side Effects:
    • Blurred vision
    • Local irritation
    • Follicular conjunctivitis
    • Vascular congestion
    • Photophobia
  • Pregnancy & Lactation:
    • Systemic absorption possible after ocular administration
    • Limited distribution into breast milk
    • Adverse effects on nursing infants reported
  • Precautions & Warnings:
    • Avoid in children with severe systemic reaction to Atropine
    • Caution in children with Down's syndrome, spastic paralysis, or brain damage
  • Overdose Effects:
    • Flushing
    • Headache
    • Fast heartbeat
    • Unusual drowsiness
    • Emergency medical attention required
  • Therapeutic Class:
    • Mydriatic and Cycloplegic agents
  • Storage Conditions:
    • Store below 30°C in a dry place away from light
    • Do not use after 1 month of first opening

Related Brands